Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)

Recruiting

Phase 3

STOP BLOQSurveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)

Sponsor:

NYU Langone Health

Code:

NCT04474223

Conditions

AVB - Atrioventricular Block

Fetal AVB

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dexamethasone

IVIG

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-29. This information was provided to ClinicalTrials.gov by NYU Langone Health on 2026-04-06.